- Scientists at the
- The AI identified two distinct centrosome defects that behave independently: an excess count of centrosomes and abnormally enlarged centrosomes.
- Tumours with high levels of enlarged centrosomes were found to be more aggressive, while lower levels correlated with higher patient survival rates.
- Researchers believe the platform could enable better forecasting of disease progression, new biomarkers and more personalised treatment strategies.
source & further reading
independent.co.uk — original article
Breakthrough as scientists use AI to predict how breast cancer could progress
More than half of Scottish businesses plan to step up investment in AI skills
Make AI adoption Britain’s national economic priority, says CBI